Accessory Gene Regulator Polymorphism and Vancomycin Minimum Inhibitory Concentration in Methicillin-Resistant Staphylococcus aureus

논문상세정보
' Accessory Gene Regulator Polymorphism and Vancomycin Minimum Inhibitory Concentration in Methicillin-Resistant Staphylococcus aureus' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • agr polymorphism
  • staphylococcus aureus
  • vancomycin
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,675 0

0.0%

' Accessory Gene Regulator Polymorphism and Vancomycin Minimum Inhibitory Concentration in Methicillin-Resistant Staphylococcus aureus' 의 참고문헌

  • Vancomycin in vitrobactericidal activity and its relationship to efficacy in clearance ofmethicillin-resistant Staphylococcus aureus bacteremia
    Moise PA AntimicrobAgents Chemother 51 : 2582 ~ 2586 [2007]
  • Vancomycin in vitrobactericidal activity and its relationship to efficacy in clearance ofmethicillin-resistant Staphylococcus aureus bacteremia
    Moise PA AntimicrobAgents Chemother 51 2582-2586 [2007]
  • Vancomycin MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureus bacteremia: trends over 11 years
    Musta AC J ClinMicrobiol 47 : 1640 ~ 1644 [2009]
  • Vancomycin MIC plus heteroresistance and outcome of methicillin-resistant Staphylococcus aureus bacteremia: trends over 11 years
    Musta AC J ClinMicrobiol 47 1640-1644 [2009]
  • Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates
    van Hal SJ Antimicrob Agents Chemother 55 : 405 ~ 410 [2011]
  • Systematic review and meta-analysis of the significance of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates
    van Hal SJ Antimicrob Agents Chemother 55 405-410 [2011]
  • Staphylococcus aureus isolates with reduced susceptibility to glycopeptides belong to accessory gene regulator group I or II
    Verdier I AntimicrobAgents Chemother 48 : 1024 ~ 1027 [2004]
  • Staphylococcus aureus isolates with reduced susceptibility to glycopeptides belong to accessory gene regulator group I or II
    Verdier I AntimicrobAgents Chemother 48 1024-1027 [2004]
  • Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia
    Khatib R J AntimicrobChemother 66 : 1594 ~ 1599 [2011]
  • Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia
    Khatib R J AntimicrobChemother 66 1594-1599 [2011]
  • Relationship between vancomycin MIC and failure among patientswith methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin
    Lodise TP Antimicrob Agents Chemother 52 : 3315 ~ 3320 [2008]
  • Relationship between vancomycin MIC and failure among patientswith methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin
    Lodise TP Antimicrob Agents Chemother 52 3315-3320 [2008]
  • Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA)
    Appelbaum PC Int J Antimicrob Agents 30 : 398 ~ 408 [2007]
  • Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA)
    Appelbaum PC Int J Antimicrob Agents 30 398-408 [2007]
  • Prevalence of agr specificity groups among Staphylococcus aureus strains colonizing children and their guardians
    Shopsin B J ClinMicrobiol 41 : 456 ~ 459 [2003]
  • Prevalence of agr specificity groups among Staphylococcus aureus strains colonizing children and their guardians
    Shopsin B J ClinMicrobiol 41 456-459 [2003]
  • Population studies of methicillin-resistant and -sensitive Staphylococcus aureus strains reveal a lack of variability in the agr D gene, encoding a staphylococcal autoinducer peptide
    van Leeuwen W J Bacteriol 182 : 5721 ~ 5729 [2000]
  • Population studies of methicillin-resistant and -sensitive Staphylococcus aureus strains reveal a lack of variability in the agr D gene, encoding a staphylococcal autoinducer peptide
    van Leeuwen W J Bacteriol 182 5721-5729 [2000]
  • Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein
    Fowler VGJr J Infect Dis 190 : 1140 ~ 1149 [2004]
  • Persistent bacteremia due to methicillin-resistant Staphylococcus aureus infection is associated with agr dysfunction and low-level in vitro resistance to thrombin-induced platelet microbicidal protein
    Fowler VGJr J Infect Dis 190 1140-1149 [2004]
  • Performance standards for antimicrobial susceptibility testing. Twenty third Informational supplement, M100-S23
    Clinical and Laboratory Standards Institute Clinical and Laboratory Standards Institute [2013]
  • Obvious lack of association between dynamics of epidemic methicillin-resistant Staphylococcus aureus in central Europe and agr specificity groups
    Strommenger B Eur J ClinMicrobiol Infect Dis 23 : 15 ~ 19 [2004]
  • Obvious lack of association between dynamics of epidemic methicillin-resistant Staphylococcus aureus in central Europe and agr specificity groups
    Strommenger B Eur J ClinMicrobiol Infect Dis 23 15-19 [2004]
  • Molecular features of heterogeneous vancomycin-intermediate Staphylococcus aureus strains isolated from bacteremic patients
    Maor Y BMC Microbiol 9 : 189 ~ [2009]
  • Molecular features of heterogeneous vancomycin-intermediate Staphylococcus aureus strains isolated from bacteremic patients
    Maor Y BMC Microbiol 9 189- [2009]
  • Methicillin-resistant Staphylococcus aureus vancomycin susceptibility testing: methodology correlations, temporal trends and clonal patterns
    van Hal SJ J AntimicrobChemother 66 : 2284 ~ 2287 [2011]
  • Methicillin-resistant Staphylococcus aureus vancomycin susceptibility testing: methodology correlations, temporal trends and clonal patterns
    van Hal SJ J AntimicrobChemother 66 2284-2287 [2011]
  • Increased mortality with accessory gene regulator (agr) dysfunction in Staphylococcus aureus among bacteremic patients
    Schweizer ML Antimicrob Agents Chemother 55 : 1082 ~ 1087 [2011]
  • Increased mortality with accessory gene regulator (agr) dysfunction in Staphylococcus aureus among bacteremic patients
    Schweizer ML Antimicrob Agents Chemother 55 1082-1087 [2011]
  • Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction
    Murakami K J ClinMicrobiol 29 : 2240 ~ 2244 [1991]
  • Identification of methicillin-resistant strains of staphylococci by polymerase chain reaction
    Murakami K J ClinMicrobiol 29 2240-2244 [1991]
  • Heteroresistance: a concern of increasing clinical significance?
    Falagas ME ClinMicrobiol Infect 14 : 101 ~ 104 [2008]
  • Heteroresistance: a concern of increasing clinical significance?
    Falagas ME ClinMicrobiol Infect 14 101-104 [2008]
  • Glycopeptide minimum inhibitory concentration creep among meticillin-resistant Staphylococcus aureus from 2006-2011 in China
    Zhuo C Int J Antimicrob Agents 41 : 578 ~ 581 [2013]
  • Glycopeptide minimum inhibitory concentration creep among meticillin-resistant Staphylococcus aureus from 2006-2011 in China
    Zhuo C Int J Antimicrob Agents 41 578-581 [2013]
  • Evidence for reduction in breakpoints used to determine vancomycin susceptibility in Staphylococcus aureus
    Wootton M Antimicrob Agents Chemother 49 : 3982 ~ 3983 [2005]
  • Evidence for reduction in breakpoints used to determine vancomycin susceptibility in Staphylococcus aureus
    Wootton M Antimicrob Agents Chemother 49 3982-3983 [2005]
  • Evaluation of intraspecies interference due to agr polymorphism in Staphylococcus aureus during infection and colonization
    Goerke C J Infect Dis 188 : 250 ~ 256 [2003]
  • Evaluation of intraspecies interference due to agr polymorphism in Staphylococcus aureus during infection and colonization
    Goerke C J Infect Dis 188 250-256 [2003]
  • Evaluation of a new Etestvancomycin-teicoplanin strip for detection of glycopeptide-intermediate Staphylococcus aureus (GISA), in particular, heterogeneous GISA
    Yusof A J ClinMicrobiol 46 : 3042 ~ 3047 [2008]
  • Evaluation of a new E test vancomycin-teicoplanin strip for detection of glycopeptide-intermediate Staphylococcus aureus (GISA), in particular, heterogeneous GISA
    Yusof A J ClinMicrobiol 46 3042-3047 [2008]
  • Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus
    Charles PG Clin Infect Dis 38 : 448 ~ 451 [2004]
  • Clinical features associated with bacteremia due to heterogeneous vancomycin-intermediate Staphylococcus aureus
    Charles PG Clin Infect Dis 38 448-451 [2004]
  • Accuracy of commercial and reference susceptibility testing methods for detecting vancomycin-intermediate Staphylococcus aureus
    Swenson JM J ClinMicrobiol 47 : 2013 ~ 2017 [2009]
  • Accuracy of commercial and reference susceptibility testing methods for detecting vancomycin-intermediate Staphylococcus aureus
    Swenson JM J ClinMicrobiol 47 2013-2017 [2009]
  • Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy
    Moise-Broder PA Clin Infect Dis 38 : 1700 ~ 1705 [2004]
  • Accessory gene regulator group II polymorphism in methicillin-resistant Staphylococcus aureus is predictive of failure of vancomycin therapy
    Moise-Broder PA Clin Infect Dis 38 1700-1705 [2004]
  • Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin
    Sakoulas G Antimicrob Agents Chemother 46 : 1492 ~ 1502 [2002]
  • Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin
    Sakoulas G Antimicrob Agents Chemother 46 1492-1502 [2002]
  • Accessory Gene Regulator Group Polymorphisms in Methicillin-Resistant Staphylococcus aureus: An Association with Clinical Significance
    윤희정 Yonsei Medical Journal 48 (2) : 176 ~ 183 [2007]
  • Accessory Gene Regulator Group Polymorphisms in Methicillin-Resistant Staphylococcus aureus: An Association with Clinical Significance
    윤희정 Yonsei Medical Journal 48 2 176-183 [2007]